Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial
Clinical trial NCT06620822 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06620822
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-09-30
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.